BusinessWire_EN's profile
Blog
Bayer’s Lynkuet® (elinzanetant), the First and Only Neurokinin 1 and Neurokinin 3 Receptor Antagonist, Receives FDA Approval for Moderate to Severe Hot Flashes Due to Menopause
Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Lynkuet® (elinzanetant) 60mg capsules, the first and only dual neurokinin (NK) targeted therapy,1 neurokinin 1 (NK1)
Tompkins Financial Corporation Reports Cash Dividend
Tompkins Financial Corporation (NYSE American: TMP)
Tompkins Financial Corporation announced today that its Board of Directors approved payment of a regular quarterly cash dividend of $0.65 per
Tompkins Financial Corporation Reports Improved Third Quarter Financial Results
Tompkins Financial Corporation (NYSE American: TMP)
Tompkins Financial Corporation ("Tompkins" or the "Company") reported diluted earnings per share of $1.65 for the third quarter of 2025, up
Circus SE Secures Core Technologies Through Six New Defense Patents
Circus SE (XETRA: CA1 / WKN: A2YN35) today announced the filing of six groundbreaking patents in the fields of defense and autonomous AI robotics. The intellectual property covers core technologies
Pershing Square Holdings, Ltd. Announces Pricing of $500 Million Senior Notes Offering
Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) announced today the pricing of $500 million aggregate principal amount of its Senior Notes due 2032 at a coupon of 5.500% per annum (the